Micron Technology MU has outperformed the market over the past 20 years by 3.31% on an annualized basis producing an average ...

The Trump trade is pulling back on recent polling data indicating Harris could take Iowa, traditionally a red state.

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Monday. The Dow traded down 0 ...

The general mood among these heavyweight investors is divided, with 0% leaning bullish and 80% bearish. Among these notable ...

AstraZeneca and Eccogene revealed promising trial data on ECC5004, an oral GLP-1 receptor agonist for obesity, showing safety, tolerability, and convenient dosing.

Wall Street prepares for sector-specific shakeups during Election Week 2024. A Democratic win could boost clean energy stocks, while a Trump victory could benefit the steel sector.

Get a first look at the PS5 Pro with enhanced GPU, extra memory, and a more compact design. Sony's latest console debuts 7.

A district court judge in Nebraska ruled that votes for and against the state's medical cannabis ballot measures will be counted and made public. With the last week's ruling Lancaster County District ...

The economic data has been mixed for the last year but remains sufficient to sustain solid GDP growth, indicating growing activity, which is good news for business services companies.

Coupang outperforms its peers in revenue growth with a rate of 25.44%, while its gross profit is at $2.14B, higher than its peers. However, Coupang's return on equity is at -1.94%, which is lower ...

During a campaign rally for presidential candidate Donald Trump at Madison Square Garden, Elon Musk suggested that he could ...

The consensus rating for Ultragenyx Pharmaceutical is Outperform, based on 6 analyst ratings. With an average one-year price target of $102.33, there's a potential 100.69% upside.